139 related articles for article (PubMed ID: 38135030)
1. The Impact of Teduglutide on Real-Life Health Care Costs in Children with Short Bowel Syndrome.
Cucinotta U; Acunzo M; Payen E; Talbotec C; Chasport C; Alibrandi A; Lacaille F; Lambe C
J Pediatr; 2023 Dec; 272():113882. PubMed ID: 38135030
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome.
Gattini D; Belza C; Kraus R; Avitzur Y; Ungar WJ; Wales PW
Clin Nutr; 2023 Dec; 42(12):2363-2371. PubMed ID: 37862822
[TBL] [Abstract][Full Text] [Related]
3. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
Zaczek Z; Jurczak-Kobus P; Panczyk M; Braszczyńska-Sochacka J; Majewska K; Kunecki M; Dąbrowska K; Sobocki J
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458196
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Effectiveness of Teduglutide Treatment in Patients with Short Bowel Syndrome in Slovakia-Multicenter Real-World Study.
Gombošová L; Suchanský M; Krivuš J; Hornová J; Havlíčeková Z; Fojtová A; Norek B; Valachová I; Šprláková J; Gazda J; Ondrušová M
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592065
[TBL] [Abstract][Full Text] [Related]
5. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
Germán-Díaz M; Alcolea A; Cabello V; Blasco-Alonso J; Rodríguez A; Galera R; García-Romero R; Romero C; González-Sacristán R; Redecillas-Ferreiro S; Moreno-Villares JM; Ramos-Boluda E
Eur J Pediatr; 2024 Apr; ():. PubMed ID: 38664251
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
Lambe C; Talbotec C; Kapel N; Barbot-Trystram L; Brabant S; Nader EA; Pigneur B; Payen E; Goulet O
Am J Clin Nutr; 2023 Jun; 117(6):1152-1163. PubMed ID: 37270289
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Home Parenteral Nutrition in France: A six years national survey.
Goulet O; Breton A; Coste ME; Dubern B; Ecochard-Dugelay E; Guimber D; Loras-Duclaux I; Abi Nader E; Marinier E; Peretti N; Lambe C
Clin Nutr; 2021 Oct; 40(10):5278-5287. PubMed ID: 34534896
[TBL] [Abstract][Full Text] [Related]
8. Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes.
de Dreuille B; Nuzzo A; Bataille J; Mailhat C; Billiauws L; Le Gall M; Joly F
Nutrients; 2023 May; 15(11):. PubMed ID: 37299413
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.
Walter E; Dawoud C; Hütterer E; Stift A; Harpain F
Am J Clin Nutr; 2024 May; 119(5):1187-1199. PubMed ID: 38431119
[TBL] [Abstract][Full Text] [Related]
10. [Review of real-life teduglutide experience].
Campos Martín C; Tejera Pérez C; Virgili-Casas N; Irles-Rocamora JA
Nutr Hosp; 2023 Aug; 40(4):886-894. PubMed ID: 37409717
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
[TBL] [Abstract][Full Text] [Related]
14. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
Lam K; Schwartz L; Batisti J; Iyer KR
JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
[TBL] [Abstract][Full Text] [Related]
15. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
[TBL] [Abstract][Full Text] [Related]
16. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.
Raghu VK; Binion DG; Smith KJ
Am J Clin Nutr; 2020 Jan; 111(1):141-148. PubMed ID: 31665212
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study.
Blüthner E; Pape UF; Tacke F; Greif S
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111167
[TBL] [Abstract][Full Text] [Related]
19. The Variable Response to Teduglutide in Pediatric Short Bowel Syndrome: A Single Country Real-Life Experience.
Guz-Mark A; Hino B; Berkowitz D; Hartman C; Millman PN; Orlanski-Meyer E; Shaoul R; Spector-Cohen I; Weiss B; Zangen T; Shamir R
J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):293-298. PubMed ID: 35730756
[TBL] [Abstract][Full Text] [Related]
20. Survival of Patients With Short-Bowel Syndrome on Home Parenteral Nutrition: A Prospective Cohort Study.
Noelting J; Gramlich L; Whittaker S; Armstrong D; Marliss E; Jurewitsch B; Raman M; Duerksen DR; Stevenson D; Lou W; Saha S; Allard JP
JPEN J Parenter Enteral Nutr; 2021 Jul; 45(5):1083-1088. PubMed ID: 32740954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]